Company profile
Chordia Therapeutics,Inc
Industry position
Pharmaceutical
Latest half-year results
H1 FY2026
Operating income was -¥662.73 million, up 33.5% year over year. Net income was -¥633.7 million, up 35.1% year over year.
Half-year trend
Half-year financial trend
H1 values are cumulative year-to-date.
H2 values are calculated when comparable.
Standalone · Japanese GAAP · Cumulative YTD
Half-year financial data
Annual key financial indicators
FY2025
Operating income was -¥1.79 billion, up 0.6% year over year. Net income was -¥1.79 billion, up 2.3% year over year. ROE was -73.3%; equity ratio was 90.8%; free cash flow was -¥1.84 billion.
Industry position details
Pharmaceutical
Annual data for the same fiscal year and industry
FY2025 Comparison sample 32
ROE Bottom 79%
Equity ratio Top 22%
Annual financial data
| Fiscal year | Scope | Accounting standard | Revenue | Operating income | Ordinary income | Profit before tax | Net income | Profit attributable to owners of parent | Comprehensive income | Total assets | Total liabilities | Net assets | Shareholders' equity | Equity | Equity attributable to owners of parent | Equity for ratio | Operating cash flow | Investing cash flow | Financing cash flow | Free cash flow | Cash and cash equivalents | Basic EPS | P/E | Share price | Market cap | Book value per share | Dividend per share | Shares issued | Equity ratio | Official equity ratio | ROE | ROA | Operating margin | Ordinary income margin | Net margin | Operating cash flow margin | Free cash flow margin | Dividend payout ratio | Revenue YoY | Operating income YoY | Ordinary income YoY | Profit before tax YoY | Net income YoY | Total assets YoY | Equity YoY | Operating cash flow YoY | Investing cash flow YoY | Financing cash flow YoY | Free cash flow YoY | Cash and cash equivalents YoY | EPS YoY | Dividend per share YoY | Shares issued YoY | Employees YoY | Average salary YoY | Employees | Average salary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Standalone | Japanese GAAP | -1789781000 | -1769669000 | -1785867000 | 2681349000 | 244338000 | 2437010000 | 2434495000 | 2437010000 | -1836921000 | -5327000 | 61580000 | -1842248000 | 2548955000 | -26.03 | 35.29 | 68988800 | 0.9088746001 | 0.908 | -0.7328106984 | -0.6660330304 | 0.0064477772 | 0.0301626508 | 0.0225819004 | -0.4211712363 | -0.4143628777 | 0.0517884133 | 0.5139155032 | -0.9583580437 | 0.0543879577 | -0.4112756674 | 0.1632915461 | 0.0193561352 | -0.0909090909 | 0.0072487014 | 20 | 11146752 | |||||||||||||||||||
| FY2024 | Standalone | Japanese GAAP | -1801396000 | -1824707000 | -1827127000 | 4632370000 | 471072000 | 4161297000 | 4158362000 | 4161297000 | -1937248000 | -10959000 | 1478797000 | -1948207000 | 4329624000 | -31.11 | 61.44 | 67678800 | 0.8983084253 | 0.898 | -0.4390763264 | -0.3944259634 | 22 | 11066534 |
Source filings
Select a document type to load the filings list.
Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp